UiPath (NYSE:PATH) has seen its stock price surge by 29.2% since July 24, closing at $14.00 on Thursday, August 6. The rally, which has captured the attention of market participants, comes just ahead of the company's fiscal second-quarter earnings report scheduled for September 3. In premarket trading on Friday, shares edged up another 0.9% to $14.13, signaling continued investor enthusiasm.
The trading volume during the four sessions from Monday to Thursday totaled 268.3 million shares, a figure that represents 58.9% of the company's outstanding Class A shares as of the end of April. Such a substantial turnover suggests that the move is more than a short-term blip, reflecting genuine interest from institutional and retail investors alike.
However, the sharp price appreciation has created a gap between market sentiment and analyst expectations. While the stock has climbed, the consensus price target among analysts stands at $13.27, which is 5.2% below Thursday's closing price. This discrepancy underscores the cautious stance many on Wall Street have adopted, with 12 analysts rating the stock as a Hold, two as Buy, and one as Sell, according to Google Finance data.
Earnings Expectations and Guidance
UiPath's management has provided guidance for the second quarter, projecting revenue in the range of $395 million to $400 million. A preliminary third-party estimate of $397.77 million is nearly at the midpoint of this range, differing by just 0.07%. This suggests that the company is on track to meet its own expectations, but the market's reaction will depend on whether it can exceed these figures.
The company's outlook indicates a deceleration in revenue growth, with an implied annual increase of 9.1% to 10.5% compared to the prior year. This slowdown is offset by improved operating leverage, as the non-GAAP operating margin is expected to rise to approximately 18.8%-19.0%, up from 17.2% a year ago. Non-GAAP operating income is projected at around $75 million, a 21% increase from the $62 million reported in the same quarter last year.
Recent Performance and Market Context
The rally in UiPath's stock has been supported by a broader surge in artificial intelligence-related investments. U.S. indexes hit all-time highs earlier in the week, driven by strong earnings from AI-focused companies. Despite a pullback in software stocks on Thursday, UiPath managed to close higher, gaining 1.3%.
Looking at the daily price action, the stock has shown resilience: July 24 saw a 6.27% gain to $10.84, followed by a 3.15% rise to $12.76 on July 31. The momentum continued into August, with the stock closing at $13.05 on August 3, $14.10 on August 4, and $14.00 on August 6, after a slight dip on August 5.
Fundamentals and Balance Sheet Strength
UiPath's first-quarter results, reported earlier, highlighted a 17% revenue increase and a 12% rise in annual recurring revenue (ARR). Non-GAAP operating income totaled $92 million, and the company achieved GAAP profitability for the first time in its history, as noted by Chief Operating Officer and CFO Ashim Gupta. CEO Daniel Dines indicated that agentic products are "moving from pilot to production," signaling confidence in the company's strategic direction.
The balance sheet remains robust, with $1.416 billion in cash and marketable securities as of April 30. Operating cash flow for the quarter was $131.9 million, while investing activities reflected a net payment of $149.4 million for acquisitions. Share repurchases have also been active, with the company buying back 20.4 million shares at an average price of $11.47 in the first quarter and an additional 2.4 million shares at $9.63 through May 15.
Investor Considerations and Risks
For investors, the key test will come on September 3, when UiPath reports its fiscal second-quarter results. The market will be watching for signs of sustained growth in net new ARR, which is guided to be between $28 million and $33 million, a range that includes the $31 million recorded in the prior-year period but falls short of the $49 million achieved in the first quarter.
Analysts remain divided on the stock's prospects. Some, like Koji Ikeda of BofA Securities, have a Sell rating with a $13 target, while others, such as Scott Berg of Needham & Company, are more optimistic with a Buy rating and a $15 target. The average target price suggests limited upside from current levels, but the strong trading volume and positive momentum could carry the stock higher if the company delivers a strong earnings report.
Risks remain, however. A revenue miss or weaker-than-expected net new ARR could reverse the rally. Conversely, continued strong retention, an increase in annual guidance, or more rapid adoption of agentic products could keep the momentum going. As always, premarket prices are subject to change ahead of regular trading hours, and investors should be prepared for volatility.
